LXCHEM Laxmi Organic Industries Q2 FY26 results (Jul–Sep 2025) and concall
Laxmi Organic reported a challenging Q2 FY26 with a 9% revenue decline and a significant drop in EBITDA and PAT, primarily due to a 20% fall in Specialty Chemicals revenue driven by product phase-outs, market price moderation, and deferred orders. Despite the headwinds, the company maintained robust cash flow from operations and is progressing with its strategic expansion projects, including the operationalization of Dahej Phase 1 and the ramp-up of its fluorination business, with a focus on cost optimization and commercial excellence.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue down 9.2%, net profit down 60.7% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 771 | 786 | 710 | 693 | 700 −9% |
| EBITDA | 75 | 75 | 59 | 31 | 37 −51% |
| Net profit | 28 | 29 | 22 | 21 | 11 −61% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
